Pharma major Zydus Cadila on Thursday reported a rise of 14.7 per cent in its consolidated net profit to Rs 25.27 crore during the first quarter ended June 30.
On a consolidated basis, the company's total income from operations was reported at Rs 115.54 crore during the quarter under review.
"During the quarter, offtake of the company's pillar brands -- Sugar Free, EverYuth and Nutralite continued to grow at a consistent pace," the company said in a statement.
"Sugar Free, India's largest selling sugar substitute, maintained its number one position with a market share of 94.6 per cent (MAT June 17 report of Nielsen), up by 50 basis points," it added.
On a closing basis, the scrips of the pharma major fell by 0.37 per cent to Rs 880.10 per share.
--IANS
ppg/pgh/bg
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app